Radiotherapy for pediatric adrenocortical carcinoma - Review of the literature

Verena Wiegering^{1

2}, Maria Riedmeier¹, Lester D R Thompson³, Calogero Virgone⁴, Antje Redlich⁵, Michaela Kuhlen⁶, Melis Gultekin⁷, Bilgehan Yalcin⁸, Boris Decarolis⁹, Christoph Härtel^{1

2}, Paul-Gerhardt Schlegel^{1

2}, Martin Fassnacht^{2

10}, Beate Timmermann¹¹

Affiliations

¹ University Childreńs Hospital, Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Wuerzburg, Josef-Schneiderstr. 2, 97080 Wuerzburg, Germany.
² Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Josef-Schneiderstr. 2, 97080 Wuerzburg, Germany.
³ Head and Neck Pathology Consultations, Woodland Hills, CA, USA.
⁴ Pediatric Surgery, Department of Woman's and Child's Health, University Hospital of Padua, Padua, Italy.
⁵ Pediatric Oncology, Otto-von-Guericke-University, Magdeburg, Germany.
⁶ Swabian Children's Cancer Center, University Children's Hospital Augsburg, Augsburg, Germany.
⁷ Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, 06100 Ankara, Turkey.
⁸ Department of Pediatric Oncology, Hacettepe University, Faculty of Medicine, 06100 Ankara, Turkey.
⁹ Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, Cologne, Germany.
¹⁰ Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Oberduerrbacherstr. 6, 97080 Wuerzburg, Germany.
¹¹ Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Germany, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany.

PMID: 35601796
PMCID: PMC9121070
DOI: 10.1016/j.ctro.2022.05.003

Review

Radiotherapy for pediatric adrenocortical carcinoma - Review of the literature

Verena Wiegering et al. Clin Transl Radiat Oncol. 2022.

. 2022 May 14:35:56-63.

doi: 10.1016/j.ctro.2022.05.003. eCollection 2022 Jul.

Authors

Affiliations

¹ University Childreńs Hospital, Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Wuerzburg, Josef-Schneiderstr. 2, 97080 Wuerzburg, Germany.
² Comprehensive Cancer Centre Mainfranken, University of Wuerzburg Medical Centre, Josef-Schneiderstr. 2, 97080 Wuerzburg, Germany.
³ Head and Neck Pathology Consultations, Woodland Hills, CA, USA.
⁴ Pediatric Surgery, Department of Woman's and Child's Health, University Hospital of Padua, Padua, Italy.
⁵ Pediatric Oncology, Otto-von-Guericke-University, Magdeburg, Germany.
⁶ Swabian Children's Cancer Center, University Children's Hospital Augsburg, Augsburg, Germany.
⁷ Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, 06100 Ankara, Turkey.
⁸ Department of Pediatric Oncology, Hacettepe University, Faculty of Medicine, 06100 Ankara, Turkey.
⁹ Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, Cologne, Germany.
¹⁰ Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Oberduerrbacherstr. 6, 97080 Wuerzburg, Germany.
¹¹ Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), Germany, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany.

PMID: 35601796
PMCID: PMC9121070
DOI: 10.1016/j.ctro.2022.05.003

Abstract

Background and purpose: Pediatric adrenocortical carcinoma (pACC) is a rare disease with poor prognosis. Publications on radiotherapy (RT) are scarce. This review summarizes the current data on RT for pACC and possibly provides first evidence to justify its use in this setting.

Materials and methods: We searched the PubMed and Embase database for manuscripts regarding RT for pACC.

Results: We included 17 manuscripts reporting on 76 patients treated with RT, after screening 2961 references and 269 full articles. In addition, we added data of 4 unreported pACC patients treated by co-authors. All reports based on retrospective data. Median age at first diagnosis was 11.1 years (70% female); 78% of patients presented with hormonal activity. RT was mostly performed for curative intent (78%). 88% of RT were administered during primary therapy. The site of RT was predominantly the local tumor bed (76%). Doses of RT ranged from 15 to 62 Gy (median 50 Gy). Information on target volumes or fractionation were lacking. Median follow-up was 6,9 years and 64% of the patients died of disease, with 33% alive without disease. In 16 of 48 patients with available follow-up data after adjuvant RT (33%) no recurrence was reported and in 3 of 9 patients palliative RT seemed to induce some benefit for the patient.

Conclusions: Our first systematic review on RT for pACC provides too few data for any general recommendation, but adjuvant RT in patients with high risk might be considered. International collaborative studies are urgently needed to establish better evidence on the role of RT in this rare malignancy.

Keywords: Pediatric adrenocortical cancer; Pediatric adrenocortical carcinoma; Pediatric adrenocortical tumor; Radiotherapy; Therapy; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

**Fig. 1**
**Search criteria** Flow diagram of the search strategy and evidence acquisition in a systematic review on Radiotherapy in Pediatric Adrenocortical Carcinoma.

See this image and copyright information in PMC

References

1. Michalkiewicz E., Sandrini R., Figueiredo B., Miranda E.C.M., Caran E., Oliveira-Filho A.G., et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838–845. - PubMed
1. Rodriguez-Galindo C., Krailo M.D., Pinto E.M., Pashankar F., Weldon C.B., Huang L.I., et al. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021;39(22):2463–2473. - PMC - PubMed
1. Abib S.C.V., Weldon C.B. Management of Adrenal Tumors in Pediatric Patients. Surg Oncol Clin N Am. 2021;30(2):275–290. - PubMed
1. Fassnacht M., Kroiss M., Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(12):4551–4564. - PubMed
1. Megerle F., Kroiss M., Hahner S., Fassnacht M. Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails? Exp Clin Endocrinol Diabetes. 2019;127(02/03):109–116. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Radiotherapy for pediatric adrenocortical carcinoma - Review of the literature

Affiliations

Radiotherapy for pediatric adrenocortical carcinoma - Review of the literature

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

LinkOut - more resources

Full Text Sources